|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
FluoroPharma Announces the Promotion of Tamara Rhein to CFO
8/23/2012 10:08:33 AM
MONTCLAIR, N.J., Aug. 22, 2012 (GLOBE NEWSWIRE) -- FluoroPharma Medical, Inc. (OTCBB:FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, is pleased to announce the promotion of Tamara Rhein to the position of Chief Financial Officer. Ms. Rhein will report directly to Thijs Spoor, FluoroPharma's Chairman, President and Chief Executive Officer. "I am delighted to promote Tamara Rhein to CFO. Since she joined FluoroPharma, she has become a valuable asset to our business. Her strong background in finance and experience in prestigious investment firms, Pharmaceuticals as well as small start-up companies further strengthens our management team," commented Mr. Spoor.
|
|
|
|
|
|
|
|
|
|
|